top of page
News
Search
Dec 5, 2023
Japanese patent awarded to hInGeTox safety assay
TestAVec's hInGeTox saftey assay has been awarded a patent from Japan. Two of TestAVec's key saftey tests, hInGeTox and DiNARep, have now...
Oct 31, 2023
TestAVec at ESGCT 2023
TestAVec went to the 30th ESGCT Congress, this year held in the beautiful city of Brussels. Robert, Mike and Saqlain attended the...
May 12, 2022
TestAVec Researchers Uncover Possible Reasons For Side Effects of HIV-1 Lentiviral Vectors
TestAVec CSO, Professor Michael Themis, also Head of the Gene Therapy research group at Brunel University London, and his team have...
Dec 24, 2021
Merry Christmas from TestAVec
From all of us at TestAVec, we wish you a wonderful Christmas and new year. We look forward to working with you in 2022.
Dec 9, 2021
The real patient benefit of gene therapy highlighted by skin transplant
In 2015, a 7 year old patient was presented at a hospital in Germany with severe burns. The patient had suffered debilitating blisters...
bottom of page